Protein-lipid vesicles and autogenous vaccine comprising the same
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 10, 1998
Grant Date -
N/A
app pub date -
Sep 11, 1996
filing date -
Sep 11, 1996
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A protein-lipid vesicle that can be used to make an autogenous vaccine comprises patient-specific antigen, adjuvant or immunomodulator, and lipid carrier. In addition, a negatively charged lipid component is desirably included. The autogenous vaccine is useful to treat individuals with chronic diseases, including chronic infectious diseases and neoplasias. The chronic infectious diseases that can be treated include disease caused by infection with human immunodeficiency viruses.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully